Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Aytu BioPharma Inc. (AYTU) had Cost of Goods Sold of $5.65M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$18.45M |
|
$3.99M |
|
|
Cost of Goods Sold |
$5.65M |
$12.81M |
|
$16.03M |
|
$2.42M |
|
$1.40M |
|
$3.82M |
|
$3.82M |
|
$3.94M |
|
$3.94M |
|
$3.99M |
|
$3.94M |
|
$2.42M |
|
$3.77M |
|
6.13M |
|
8.20M |
|
$0.65 |
|
$0.21 |
|
| Balance Sheet Financials | |
$72.51M |
|
$0.55M |
|
$51.69M |
|
$124.20M |
|
$70.71M |
|
$9.54M |
|
$18.60M |
|
$89.30M |
|
$34.90M |
|
$-13.81M |
|
$34.90M |
|
6.17M |
|
| Cash Flow Statement Financials | |
$-4.74M |
|
$0.46M |
|
$2.45M |
|
$20.01M |
|
$18.17M |
|
$-1.83M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
0.21 |
|
0.61 |
|
69.40% |
|
13.12% |
|
13.12% |
|
-- |
|
20.69% |
|
21.65% |
|
$-4.28M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.51 |
|
0.52 |
|
174.74 |
|
11.29% |
|
-28.52% |
|
3.17% |
|
8.87% |
|
$5.66 |
|
$-0.52 |
|
$-0.58 |
|